Placebo: Normal saline
Sponsors
Baxalta now part of Shire, Dartmouth-Hitchcock Medical Center, Indiana University, King's College London, University of Virginia
Conditions
Chemical TerrorismChemical WarfareChronic Obstructive Pulmonary DiseaseFractures, OpenHealthy ParticipantsHealthy VolunteersInfectionNon-cystic Fibrosis Bronchiectasis
Phase 1
Pharmacokinetic (PK) and Safety Study of Plasma-derived Human Butyrylcholinesterase Administered Intravenously
CompletedNCT00333515
Start: 2007-01-01End: 2008-08-01Updated: 2021-05-05
A Study of Plasma-Derived Human Butyrylcholinesterase Administered Intramuscularly
CompletedNCT00333528
Start: 2007-12-01End: 2008-08-01Updated: 2021-05-05
Inflammatory Response In Schizophrenia
CompletedNCT03093064
Start: 2017-04-01End: 2023-08-07Updated: 2024-03-08
A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled Rev-56 in Adult Healthy Volunteers and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic P. Aeruginosa
Not yet recruitingNCT07709494
Start: 2026-07-01End: 2027-06-01Target: 64Updated: 2026-07-16